Status:
NOT_YET_RECRUITING
Heart Rate Variability of Premature Newborn
Lead Sponsor:
Federal University of Uberlandia
Collaborating Sponsors:
Adriano de Oliveira Andrade
Conditions:
Autonomic Nervous System Imbalance
Eligibility:
All Genders
28-32 years
Phase:
NA
Brief Summary
To analyze the effects of two CPAP methods on the HRV of PTNBs during their routine routine in the HCUFU neonatal ICU. This is a randomized clinical trial, with controlled groups and cross over with h...
Eligibility Criteria
Inclusion
- All preterm infants between 28 and 32 weeks of gestation using nasal CPAP and who are at least 8 and at most 12 days old will be included in the study.
Exclusion
- hemodynamic instability,
- hydroelectrolyte disorders that influence cardiac function,
- post-operative,
- congenital abnormalities,
- pulmonary hypertension,
- decompensated ductus arteriosus,
- untreated atelectasis,
- pneumothorax,
- newborns who are using drains, whether chest or abdominal,
- presence of necrotizing enterocolitis
- grade 3 nasal septum injury,
- signal captured without the necessary quality to be used in research,
- premature babies who, for whatever reason, do not have two collections carried out on consecutive days until the twelfth day of life.
Key Trial Info
Start Date :
June 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT06217133
Start Date
June 1 2024
End Date
June 1 2025
Last Update
January 22 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.